1. Cooperation between PRMT1 and PRMT6 drives lung cancer health disparities among Black/African American men
- Author
-
Pei-Ying Wu, Michelle Van Scoyk, Stephanie S. McHale, Chu-Fang Chou, Gregory Riddick, Kamran Farouq, Bin Hu, Vita Kraskauskiene, Jennifer Koblinski, Charles Lyons, Arjun Rijal, Vignesh Vudatha, Dongyu Zhang, Jose G. Trevino, Rachit D. Shah, Patrick Nana-Sinkam, Yong Huang, Shwu-Fan Ma, Imre Noth, Chanita Hughes-Halbert, Victoria L. Seewaldt, Ching-Yi Chen, and Robert A. Winn
- Subjects
Health disparity ,Molecular biology ,Cancer ,Science - Abstract
Summary: Lung cancer is the third most common cancer with Black/AA men showing higher risk and poorer outcomes than NHW men. Lung cancer disparities are multifactorial, driven by tobacco exposure, inequities in care access, upstream health determinants, and molecular determinants including biological and genetic factors. Elevated expressions of protein arginine methyltransferases (PRMTs) correlating with poorer prognosis have been observed in many cancers. Most importantly, our study shows that PRMT6 displays higher expression in lung cancer tissues of Black/AA men compared to NHW men. In this study, we investigated the underlying mechanism of PRMT6 and its cooperation with PRMT1 to form a heteromer as a driver of lung cancer. Disrupting PRMT1/PRMT6 heteromer by a competitive peptide reduced proliferation in non-small cell lung cancer cell lines and patient-derived organoids, therefore, giving rise to a more strategic approach in the treatment of Black/AA men with lung cancer and to eliminate cancer health disparities.
- Published
- 2024
- Full Text
- View/download PDF